新的平台筛选中心使得通过远程保健更容易获得早期1型糖尿病筛查。 New platform Screening Central makes early Type 1 diabetes screening more accessible via telehealth.

与Sanofi合作开发的名为 " 筛选中心 " 的新远程保健平台正在使早期1型糖尿病(T1D)筛查更容易获得。 A new telehealth platform called Screening Central, developed with Sanofi, is making early Type 1 diabetes (T1D) screening more accessible. 使用者可以要求通过三步程序进行自动体格检查:填写问卷、接受保健提供者的评估、通过电话或视频电话接收结果。 Users can request autoantibody screening through a three-step process: completing a questionnaire, getting evaluated by a healthcare provider, and receiving results via phone or video call. 这一创新旨在减少检查障碍,促进早期发现,这有助于更有效地管理病情,防止严重并发症。 This innovation aims to ease barriers to screening and promote early detection, which can help manage the condition more effectively and prevent severe complications.